∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
---|---|---|---|---|
FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (3° anno)
|
|
Ongoing | 2023 |
INTLI - Finanziamenti internazionali |
The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
FON_NAZ - Bandi Altre Fondazioni |
All-optical fingerprinting of metastatic potential (5° anno)
|
|
Ongoing | 2023 |
FON_NAZ - Bandi Altre Fondazioni |
The natural antisense lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
FON_NAZ - Bandi Altre Fondazioni |
Functional study on a new pharmacological approach in the Rett Syndrome
|
|
Ongoing | 2023 |
DECC - Bando Dipartimenti di Eccellenza |
Assegnazione Dipartimenti di Eccellenza 2023-2027 - Dipartimento di BIOTECNOLOGIE MEDICHE E MEDICINA TRASLAZIONALE
|
|
Ongoing | 2023 |
FON_NAZ - Bandi Altre Fondazioni |
Functional relevance of different tetraspanin-like MS4A members for FcRs antitumor activities in target therapies (2° anno)
|
|
Closed | 2022 |
FON_NAZ - Bandi Altre Fondazioni |
The interplay between HPCAL4 and MeCP2: identification and characterization of a novel putative target for Rett syndrome therapy
|
|
Ongoing | 2022 |
INTLI - Finanziamenti internazionali |
Dissecting the molecular mechanism linking GCase-dependent lysosomal impairment with Parkinson’s disease
|
|
Closed | 2022 |
FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (2° anno)
|
|
Closed | 2022 |